Activation of transcription is the ultimate endpoint for many signal transduction and developmental pathways, and understanding the mechanism of activation is a key to understanding gene regulation. From previous studies, it is clear that disruption of normal gene regulation by mutations in gene- specific transcription activators and coactivators can lead to cancer and other diseases. The broad long- term objectives of this proposal are to determine the mechanisms used by gene-specific activators and coactivators to regulate RNA polymerase II transcription. The proposed work will provide a basis for understanding gene regulation in normal and diseased states at the molecular level.
The specific aims of this work utilize biochemical, structural, and molecular genetic methods to examine the direct targets of two activation domains and two coactivators. We will examine the structure of several acidic activator-coactivator complexes to understand how activators specifically recognize their targets, common principals of activator-target recognition and, more generally, the function of intrinsically disordered proteins. We will examine the interaction of the SAGA coactivator with TBP (TATA binding protein) and how this interaction is regulated by acetylation. Using a unique set of crosslinking reagents, we will examine the direct targets of the Mediator coactivator complex within the transcription machinery. In all cases, we will use yeast molecular genetics to test the functional significance of our biochemical results. Combined, our results will lead to a molecular model for how activators recognize their coactivator targets and how coactivators stimulate gene expression by direct interaction with the transcription machinery.
Project Narrative The objective of this research is to understand the mechanism and regulation of transcription, the process of mRNA synthesis. Regulation of transcription is one of the key steps in control of cell growth, differentiation, and development, and defects in transcription directly contribute to many human illnesses. Understanding the mechanism of transcription and its regulation will form the basis for understanding the molecular defects in transcription disorders leading to many types of cancer, as well as heart disease, neurological disorders, and birth defects.
|Baptista, Tiago; Grünberg, Sebastian; Minoungou, Nadège et al. (2017) SAGA Is a General Cofactor for RNA Polymerase II Transcription. Mol Cell 68:130-143.e5|
|Grünberg, Sebastian; Zentner, Gabriel E (2017) Genome-wide characterization of Mediator recruitment, function, and regulation. Transcription 8:169-174|
|Grünberg, Sebastian; Henikoff, Steven; Hahn, Steven et al. (2016) Mediator binding to UASs is broadly uncoupled from transcription and cooperative with TFIID recruitment to promoters. EMBO J 35:2435-2446|
|Warfield, Linda; Tuttle, Lisa M; Pacheco, Derek et al. (2014) A sequence-specific transcription activator motif and powerful synthetic variants that bind Mediator using a fuzzy protein interface. Proc Natl Acad Sci U S A 111:E3506-13|
|Han, Yan; Luo, Jie; Ranish, Jeffrey et al. (2014) Architecture of the Saccharomyces cerevisiae SAGA transcription coactivator complex. EMBO J 33:2534-46|
|Hahn, Steven (2014) Ellis Englesberg and the discovery of positive control in gene regulation. Genetics 198:455-60|
|Grünberg, Sebastian; Hahn, Steven (2013) Structural insights into transcription initiation by RNA polymerase II. Trends Biochem Sci 38:603-11|
|Knutson, Bruce A (2013) Emergence and expansion of TFIIB-like factors in the plant kingdom. Gene 526:30-8|
|Knutson, Bruce A; Hahn, Steven (2011) Domains of Tra1 important for activator recruitment and transcription coactivator functions of SAGA and NuA4 complexes. Mol Cell Biol 31:818-31|
|Brzovic, Peter S; Heikaus, Clemens C; Kisselev, Leonid et al. (2011) The acidic transcription activator Gcn4 binds the mediator subunit Gal11/Med15 using a simple protein interface forming a fuzzy complex. Mol Cell 44:942-53|
Showing the most recent 10 out of 15 publications